Shalom Life | March 03, 2014

21-Year-Old Israeli's App Sold to Apple For Approx $40 Million

The personal assistance app, Cue, to give Apple a leg up on its competition with Google Now

By: Emily Brewes

Published: October 9th, 2013 in Business » Israel

The Israeli-developed app Cue, formerly known as Greplin, shut down this weekend after being purchased by Apple for approximately $40 million.

This represents a significant increase in value from the over $4 million of startup capital the company, co-founded by young 21-year-old Israeli entrepreneur Daniel Gross, raised in 2011.

Cue is a personal assistant app that melds your social media updates and personal calendar into one searchable daily agenda.

Gross, born and raised in Jerusalem, was set to enlist in the Israel Defense Forces when he got accepted to an incubator program in San Francisco. The program, run by Y-Combinator, offers start-ups an intensive 3-month program aimed at developing and refining broad-stroke ideas into enticing investment pitches.

He co-founded Cue with veteran entrepreneur Robbie Walker, with the initial demo hashed out during the last 48 hours of the program. "I got a weird reaction," Gross told Inc.com shortly after their initial launch. "I was a disheveled 18-year-old kid. But the idea had support."

Tech intelligentsia guess that Apple's move to buy Cue is their bid to provide more personal assistant features for the iPhone. Their direct competition, Google Now, already has much of the functionality of Cue for users of Gmail. Apple hopes to expand functionality of their existing personal assistant apps, including smoother integration of its vocal command system, Siri.

According to Times of Israel, Cue's team of several dozen employees will now be working for Apple.

Cue has already been covered by several prominent publications including TechCrunch, Forbes, Haaretz, and many more.

Jewish Top 10s: Israeli Startups to Watch in 2014 Jewish Top 10s: Israeli Startups to Watch in 2014 Trending Startup Club: Cellrox Trending Israel Researchers Look to Bring Night Vision to your Ray-Bans Trending
 

Top 20 Under 40 - Caissie Levy

March 03, 2014 | By Ashley Baylen

Caissie Levy is set to appear in the Broadway revival of 'Les Miserables' as Fantine starting later this month.

Read More

Hollywood A-Listers Revamp Classic Internet Videos on Kimmel's 'After the Oscars' [VIDEO]

March 03, 2014 | By Ashley Ramnarain
Hollywood A-Listers Revamp Classic Internet Videos on Kimmel's 'After the Oscars' [VIDEO]

Joseph Gordon-Levitt, Seth Rogen, and others star in a 3D musical rendition of 'David After the Dentist'

Read More

The Nosh Pit - Kosher Caribbean Recipes

March 03, 2014 | By Sarah Bauder
The Nosh Pit - Kosher Caribbean Recipes

If you can't go on a real vacation at this time of the year, escape to tropical climates in your kitchen with these yummy Caribbean recipes.

Read More

Bette Midler Brings Audiences to Tears During Oscars 'In Memoriam' Performance

March 03, 2014 | By Ashley Ramnarain

The legendary singer performs 'Wind Beneath My Wings' in a dedicated to film industry professionals that have passed away over the last year.

Read More

Idina Menzel aka 'Adele Naseem' Performs Magical Version of 'Frozen's' 'Let it Go'

March 03, 2014 | By Ashley Ramnarain

The 'Wicked' star was ravishing on stage at last night's awards show

Read More

IDF Hero Proposes Publicly

March 03, 2014 | By Graham Sigurdson

Captain Ziv Shilon proposed to his girlfriend in front of 1,000 Friends of the IDF supporters

Read More

Thanks to Hummus, Chickpea Demand is on the Rise in America

March 03, 2014 | By Graham Sigurdson
Thanks to Hummus, Chickpea Demand is on the Rise in America

The increasing popularity of hummus has proven beneficial for American farmers, and is poised to become even more popular thanks to the proposed Farm Bill

Read More

Israeli Researchers Develop New Methods To Battle Ovarian Cancer

March 03, 2014 | By NoCamels Team
Israeli Researchers Develop New Methods To Battle Ovarian Cancer

Tel Aviv University's Professor Dan Peer has proposed a new strategy using a nanoscale drug-delivery system designed to target specific cancer cells

Read More

More Headlines